|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,434.00 JPY | -1.17% |
|
+0.08% | -9.81% |
| 06-15 | Goldman Sachs Upgrades Chugai Pharmaceutical to Buy from Neutral; Price Target is 8,950 Yen | MT |
| 05-26 | Major Asian Stock Markets Fall Amid Renewed Middle East Tensions | MT |
| Market Cap | 12,235B 75.74B 66.53B 61.31B 57.39B 108B 7,174B 109B 736B 285B 3,520B 284B 278B | P/E 2026 * |
24x | P/E 2027 * | 20.6x |
|---|---|---|---|---|---|
| Enterprise Value | 11,312B 70.02B 61.52B 56.68B 53.06B 99.42B 6,633B 101B 681B 263B 3,255B 263B 257B | EV / Sales 2026 * |
8.16x | EV / Sales 2027 * | 7.21x |
| Free-Float |
38.12% | Yield 2026 * |
1.84% | Yield 2027 * | 2.11% |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | -1.17% | ||
| 1 week | +0.08% | ||
| Current month | -5.80% | ||
| 1 month | -8.11% | ||
| 3 months | -14.06% | ||
| 6 months | -10.02% | ||
| Current year | -9.81% |
| 1 week | 7,386 |  | 7,689 |
| 1 month | 7,270 | | 8,215 |
| Current year | 7,270 | | 10,700 |
| 1 year | 5,942 | | 10,700 |
| 3 years | 3,767 | | 10,700 |
| 5 years | 3,191 | | 10,700 |
| 10 years | 1,003.33 | | 10,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 63 | 2020-12-31 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | - | 2024-03-27 |
Junichi Nezu
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Motoo Ueno
BRD | Director/Board Member | 68 | 1993-02-28 |
Masayuki Oku
BRD | Director/Board Member | 81 | 2015-02-28 |
| Director/Board Member | 77 | 2017-02-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.17% | +0.08% | +3.41% | +74.34% | 76.7B | |
| +0.45% | -1.37% | +43.66% | +141.28% | 983B | |
| +3.37% | +1.66% | +58.00% | +44.48% | 557B | |
| +2.07% | +5.52% | +27.75% | +72.72% | 406B | |
| +1.53% | -1.93% | +23.33% | +16.35% | 314B | |
| +2.26% | +2.95% | +30.77% | +17.16% | 273B | |
| +2.61% | +2.66% | +30.07% | +37.04% | 272B | |
| +2.60% | +7.76% | -35.32% | -43.32% | 203B | |
| +0.66% | -0.24% | +27.37% | +52.79% | 186B | |
| +0.14% | -1.71% | +17.76% | +61.42% | 155B | |
| Average | +1.51% | -0.70% | +22.68% | +47.43% | 342.7B | |
| Weighted average by Cap. | +1.63% | -2.14% | +32.49% | +66.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,387B 8.59B 7.54B 6.95B 6.51B 12.19B 813B 12.4B 83.45B 32.3B 399B 32.23B 31.54B | 1,535B 9.5B 8.35B 7.69B 7.2B 13.49B 900B 13.72B 92.36B 35.75B 442B 35.67B 34.91B |
| Net income | 509B 3.15B 2.77B 2.55B 2.39B 4.47B 298B 4.55B 30.61B 11.85B 146B 11.82B 11.57B | 593B 3.67B 3.23B 2.97B 2.78B 5.21B 348B 5.3B 35.69B 13.82B 171B 13.78B 13.49B |
| Net Debt | -923B -5.71B -5.02B -4.62B -4.33B -8.11B -541B -8.24B -55.51B -21.49B -265B -21.44B -20.98B | -1,166B -7.22B -6.34B -5.84B -5.47B -10.25B -684B -10.42B -70.14B -27.15B -335B -27.09B -26.51B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-23 | JP¥7,434.00 | -1.17% | 2,411,300 |
| 26-06-22 | JP¥7,522.00 | -0.37% | 1,238,100 |
| 26-06-19 | JP¥7,550.00 | -0.21% | 3,697,700 |
| 26-06-18 | JP¥7,566.00 | -1.10% | 1,954,000 |
| 26-06-17 | JP¥7,650.00 | +1.69% | 1,745,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4519 Stock
Select your edition
All financial news and data tailored to specific country editions
